ALISO VIEJO, Calif., May 31, 2018 /PRNewswire/ — MicroVention, Inc., a U.S.-based subsidiary of Terumo and a global neurovascular company, announced today the FDA Premarket Approval (PMA) for the LVIS® and LVIS® Jr. stents for stent-assisted coil embolization of intracranial aneurysms. The LVIS® and LVIS® Jr. stents are the first and only stents PMA approved for […]
Financial
Teleflex to Present at the 39th Annual Goldman Sachs Global Healthcare Conference
WAYNE, Pa.–(BUSINESS WIRE)–Thomas Powell, Executive Vice President and Chief Financial Officer, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 39th Annual Goldman Sachs Global Healthcare Conference at the Terranea Resort, Rancho Palos Verdes, California, on Wednesday, June 13, 2018 at 2:40 p.m. (PT). A live audio webcast of the […]
Espero BioPharma to Present at the 2018 BIO International Convention, Wednesday, June 6, 2018
JACKSONVILLE, Fla., May 30, 2018 (GLOBE NEWSWIRE) — Espero BioPharma, Inc., (the “Company”) a biopharmaceutical company focusing on the late-stage development and commercialization of drugs to treat cardiovascular diseases, today announced that Quang Pham, Espero’s Chief Executive Officer, will present at the 2018 BIO International Convention at 2:00 PM ET […]
Ancora Heart Announces $17.8 Million Financing for First-of-Its-Kind Therapy for Systolic Heart Failure
SANTA CLARA, Calif.–(BUSINESS WIRE)–Ancora Heart, Inc., a company developing a novel therapy to address heart failure, today announced the closing of an initial tranche of $17.8 million in a financing round expected to reach $30 million, led by Savitr Capital and other existing investors. Ancora Heart’s AccuCinch® Ventricular Repair System is […]
Zenosense, Inc.: MIDS Shareholder Update
VALENCIA, SPAIN, May 24, 2018 (GLOBE NEWSWIRE) — Zenosense, Inc. (OTC PINK: ZENO) (“Zenosense”, the “Company”), a healthcare technology company primarily focused on the development and commercialization of MIDS Cardiac™, a Point of Care handheld device for the early detection of certain cardiac event biomarkers. We believe that MIDS Cardiac will […]
QT Vascular Enters Into Asset Purchase And Option Agreement With Teleflex
SINGAPORE, May 24, 2018 /PRNewswire/ — QT Vascular Ltd., (“QT Vascular“, and with its subsidiaries, the “Company“), announced today that it has entered into an asset purchase and option agreement (the “APOA“) with Teleflex Life Sciences Unlimited Company and Teleflex Incorporated (“Teleflex“). Under the APOA, Teleflex will acquire the non-drug coated product line […]
Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results
DUBLIN – May 24, 2018 – Medtronic plc (NYSE: MDT) today announced financial results for its fourth quarter and fiscal year 2018, which ended April 27, 2018. The company reported fourth quarter worldwide revenue of $8.144 billion, an increase of 2.9 percent as reported, or 6.5 percent on an organic basis, […]
Venus Medtech’s strategic investment in Keystone Heart deepens the technical layout of cerebral embolic protection market
HANGZHOU, China, May 23, 2018 /PRNewswire/ — China Venus Medtech (Hangzhou) Inc. announced a partnership agreement for strategic investment and authorization with Keystone Heart. This agreement will grant Venus Medtech the right to exclusively develop, manufacture and sell the 3rd generation TriGUARD 3™ device and the next generation of cerebral embolic protection device in China and […]
Analytics 4 Life® Expands Its Medical Advisory Board with Global Experts in Cardiology
RESEARCH TRIANGLE PARK, N.C. & TORONTO–(BUSINESS WIRE)–Analytics 4 Life, a digital health company applying the power of artificial intelligence to develop solutions that improve existing care pathways, today announced that it has expanded its Medical Advisory Board with the addition of two global experts in cardiology and digital health. Junbo […]
Acarix appoints senior cardiovascular medtech marketing expert as member of the Board of Directors
Malmö, May 23, 2018 Acarix appoints senior cardiovascular medtech marketing expert as member of the Board of Directors Acarix, developer of the CADScor®System for Coronary Artery Disease (CAD) risk assessment, today announced the appointment of a highly experienced marketing expert, Johanne Louise Brændgaard, as a member of the board of […]



